(Q28244460)
Statements
Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome (English)
0 references
November 2011
0 references
141
0 references
5
0 references
1638-47.e1-7
0 references
1 reference
1 reference
1 reference